UPLOAD Filing
ROCKET PHARMACEUTICALS, INC. (RCKT, RCKTW) (CIK 0001281895)
Date: March 6, 2026 · CIK: 0001281895 · Accession: 0000000000-26-002361
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293925
Letter
Re: Rocket Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed March 2, 2026 File No. 333-293925 Dear Gaurav Shah:
March 6, 2026
Gaurav Shah Chief Executive Officer Rocket Pharmaceuticals, Inc. 9 Cedarbrook Drive Cranbury, NJ 08512
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Sean M. Jones
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 6, 2026 Gaurav Shah Chief Executive Officer Rocket Pharmaceuticals, Inc. 9 Cedarbrook Drive Cranbury, NJ 08512 Re: Rocket Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed March 2, 2026 File No. 333-293925 Dear Gaurav Shah: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Sean M. Jones </TEXT> </DOCUMENT>